The Ernst Strüngmann Institute (ESI) for Neuroscience

On 12 September 2008, Dr. Andreas and Dr. Thomas Strüngmann founded the Ernst Strüngmann Institute (ESI). The ESI has the legal form of a “gemeinnützige Gesellschaft mit beschränkter Haftung (gGmbH)”, i.e. a non-profit corporation, with the Strüngmann brothers as “Gesellschafter” (partners). To finance the ESI, Dr. Andreas and Dr. Thomas Strüngmann founded the Ernst Strüngmann Foundation (ESF).

ESI’s founding directors are Prof. Wolf Singer and Prof. Pascal Fries. Mid July 2009, Prof. Fries became ESI’s first director and thereby ESI’s current managing director. On 1 April 2011, when Prof. Singer assumed emeritus status at the Max Planck Institute for Brain Research, he joined the ESI as Senior Research Group leader. On 1 October 2011, Dr. Ilka Diester joined the ESI as Research Group leader. On 1 August 2014, Ilka moved to a professorship at Freiburg University. On 1 May 2012, Dr. Michael Schmid started his Emmy Noether group at the ESI. On 1 July 2016, Martin Vinck started his Research group at the ESI. Thus, currently, the ESI comprises the department of Prof. Fries (Fries Lab), the Senior Research Group of Prof. Singer (Singer Lab), the Research Group of Dr. Hermann Cuntz (Cuntz Lab) and the Research Group of Dr. Martin Vinck (Vinck Lab).

On the pages below more information can be found about the benefactors of ESI, the Max Planck Society and the different boards that govern and evaluate ESI.

Animal Research

Insights gained in basic research Ever since their existence, humans have been seeking knowledge. Such knowledge enables them to evaluate the possible consequences of their actions and, where appropriate, look for alternatives. The insights gained in basic research also serve as the basis for new technologies, materials, treatments, and drugs. However, to gain biological and medical insights scientists often must rely on studies with living organisms. The Max Planck Society acknowledges its responsibility for the welfare of the animals kept in its laboratories.

Read more »


Max Planck Society IMPRS for Neural Circuits (Graduate School) Ernst Strüngmann Forum Brain Imaging Center (Frankfurt) Frankfurt Institute for Advanced Studies Interdisciplinary Center for Neuroscience Frankfurt (ICNF) Human Connectome Project Max Planck Institute of Neurobiology Max Planck Institute of Biophysics Max Planck Institute for Brain Research Max Planck Institute for Empirical Aesthetics Max Planck School of Cognition Max Planck Neuroscience Donders Institute for Brain, Cognition and Behaviour Society for Neuroscience (SfN)

Read more »


Dr. Andreas and Dr. Thomas Strüngmann The twins Drs. Andreas and Thomas Strüngmann were born in 1950. They both did a university study and obtained PhDs; Andreas as a medical doctor, Thomas as an economist. Whereas Andreas gained experience in the medical field by working in hospitals in South-Africa, Thomas worked his way up in the US-company Schering-Plough in New York. In 1979, the brothers were asked by their father to team up into the generic-selling family business Durachemie.

Read more »

Consultative Board

The ESI consultative board is a central element in linking the institute to the public and society. It is composed of representatives of regional politics, university, economy, media and foundations. The members are: Politics Irene Bauerfeind-Roßmann(Ministerialdirigentin State Ministery of Science) Dr. Ina Hartwig (Stadträtin of the Magistrat Frankfurt am Main) University and university medical center Prof. Dr.Birgitta Wolff (President of University of Frankfurt) Prof. Dr. Josef Pfeilschifter (Dean of the Medical School of University of Frankfurt) Prof.

Read more »

ESI Board

The ESI Board decides on all overarching scientific questions. It consists of eight members appointed by the Max Planck Society (two members of which one is the chairman) and the benefactors Drs. Andreas and Thomas Strüngmann (four members). One member is jointly appointed by the Max Planck Society and the benefactors. The Managing Director of ESI is also a member of the Board. Members are appointed for five years.

Read more »

Max Planck Society

The Max Planck Society for the Advancement of Science is an independent, non-profit research organization. It was founded on February 26, 1948, and is the successor organization to the Kaiser Wilhelm Society, which was established in 1911. The primary goal of the Max Planck Society is to promote research at its own institutes. The research institutes of the Max Planck Society perform basic research in the interest of the general public in the natural sciences, life sciences, social sciences, and the humanities.

Read more »

Mission Statement

The ESI’s mission is to conduct excellent fundamental brain research. The focus lies on the systems neuroscience level, at which we try to understand how the many neurons of the brain work together to bring about our conscious experiences and our behavior. To this end, ESI researchers develop new scientific concepts and new recording and analysis methods to test them, often in collaboration with national and international partners. New insights and methods are disseminated through publications, workshops, conferences and teaching activities.

Read more »

Scientific Advisory Board

The Scientific Advisory Board will be involved in the scientific evaluation of ESI. It will advise ESI Board on the scientific developments and the allocation of funds. The members are appointed for six years. The chairman is appointed by the members themselves. The Scientific Advisory Board will in principle meet every two years. ESI will be evaluated every six years via the protocol designed by the Max Planck Society. Prof.

Read more »

Dr. Ernst Strüngmann

Dr. Ernst Strüngmann was born in 1914 in Duisburg. After the war he settled as an ophthalmologist in Mühlheim/Ruhr and, in parallel, founded the company Durachemie. Initially, the firm developed ophthalmological products, but in 1969, Dr. Ernst Strüngmann expanded his business into the generic market. In 1979 two of his three sons, Andreas and Thomas, entered the family business, which they further developed and, in 1986, sold to the firm Cyanamid Lederle.

Read more »